CD86 and neoplasm: In pancreatic ductal adenocarcinoma (PDAC), TMAO resulted in increased expression of co‐stimulatory markers such as MHCI, MHCII and CD86 in TAM and reformulated the tumour environment to an immune‐activated state to inhibit tumour growth.51, 67